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Background
Cardiovascular diseases are one of the main causes of
mortality in many parts of the world, with atherosclero-
sis figuring as the principal cause of coronary occlusion,
stroke and aortic aneurysm [1]. Saphenous vein is the
most commonly used vascular prosthesis for small-cali-
ber (< 6 mm) vascular grafts, however, 10%-40% of
patients do not have a saphenous vein suitable for pros-
thetic replacement due to size mismatch or venous dis-
ease [2]. Tissue engineering approaches are being used
to develop palliative methods for these pathologies such
as the construction of artificial blood vessels. The pur-
pose of this study was to biosynthesize artificial vessels
using Gluconacetobacter hasenii’s bacterial cellulose
(BC) as scaffolding [3]. Functional and structural charac-
teristics of the vessels were evaluated, as well as the
coating of the cellulolytic tubular scaffolding with
human aortic smooth muscle cells (HASMC). The ves-
sels obtained exhibited appropriate mechanical proper-
ties and their morphology showed connected nonporous
and porous phases as a basis to mimic, respectively, the
intimal and medial layers of a blood vessel. In vitro cul-
tures of HASMCs in the presence of tubular scaffolds
demonstrated their ability to support colonization by
human aortic smooth muscle cells.
Methods
BC vessels were developed using G. hansenii (ATCC
2376) grown in a mannitol, yeast extract and peptone
medium, in an Erlenmeyer flask, containing a silicone
tube (4 mm inside diameter) connected to a circulation
air pump. Bacterial cells were cultured for 12 days
under static conditions and allowed BC biosynthesis
around the template tube. The artificial vessels were
then washed with NaOH (0.1 mol L-1) sterilized by
autoclaving. To assess the effect of the artificial device
on human cell viability, primary cultures of HASMC
were grown over the BC vessels, in a 231 medium at
37ºC with 5% of CO2. Vessels’ morphology was evalu-
ated by scanning electron microscopy (SEM) and the
mechanical properties of the vessels assessed by tensile
tests. For the viability assays, cells were seeded at a con-
centration of 15 × 105 cell/vessel, grown in the nonpor-
ous side of the membrane and analyzed by MTS
colorimetric assay [3-(4,5-dimethylthiazol-2-yl)-5-(3-car-
boxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium],
after 24, 48, 72h and 7, 14 days of culture. The absor-
bance was quantified at 490 nm in a microplate reader.
Results and conclusions
SEM analysis showed that BC vessels are composed of
fibers with a nonporous surface formed at the liquid/
solid/air interface (inside the vessel), followed by a por-
ous layer (outside the vessel). Tensile tests showed simi-
lar burst strength of the cellulose vessel when compared
to a native blood vessel (224 ± 41 kPa). Human cells
remained viable over the BC scaffolding for up to 14
days, the total duration of the experiment indicating
that BC vessels represent a suitable support for cell
colonization. Results presented here highlight the poten-
tial of BC as a biomaterial for vascular tissue engineer-
ing and its applications as a model for artificial blood
vessels.
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